Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
#3502 Lifestyle and neuroendocrine tumor (NET) development
Introduction: There has been increasing interest in the relationship between lifestyle and NET. However, no review focusing solely on lifestyle as a risk factor for NET has previously been performed.
Conference:
Presenting Author: Bogaards M
Authors: Bogaards M, May A, Hassan F, Valk G, van Leeuwaarde R,
Keywords: neuroendocrine tumor, smoking, alcohol, diet, physical activity, body mass index, lifestyle,
Introduction: Metabolic syndrome and obesity (MetS) are supposed to have a role in cancer but data analysing their association with GEP-NET are lacking.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Modica R
Authors: Modica R, Barrea L, Bottiglieri F, de Cicco F, Minotta R,
Keywords: GEP-NET, metabolic syndrome, visceral adiposity index, fatty liver index,
Introduction: Neuroendocrine tumors are rare. A very little knowledge is known about its risk factors. Studies have shown that NETs may develop as a part of hereditary syndromes.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Fatima A
Keywords: Genetics, NETs, First degree relatives,
#686 Hepatic Arterial Embolization for Gastroenteropancreatic NET Liver Metastases
Introduction: Selective hepatic arterial embolization (HAE) with polyvinyl alcohol particles has been shown to be equivalent to chemoembolization for patients with hepatic gastroenteropancreatic (GEP) neuroendocrine metastases. There remains debate about its clinical effectiveness and which patients benefit from treatment.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Wilson C
Authors: Wilson C, Vallance A, Bernstone G, Williams R, Jackson R,
Keywords: hepatic arterial embolisation,
#546 Treatment of Malignant Neuroendocrine Tumors of the Hepatopancreatododenal Region
Introduction: The incidence of malignant NETs of the hepatopancreatoduodenal region is currently set at 10-15 cases per 100,000 people. Patient treatment and prognosis differ from those with adenocarcinoma.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Egorov A, Musaev G, Kondrashin S, Gurevich L, Fominyh E,
Keywords: malignant, neuroendocrine tumor, surgery,